Saeidnia M, Nam Avar Jahromi F, Vaziee E, Dehghani H, Mahmoodzade A, Tamaddon G. Thrombotic Thrombocytopenic Purpura: Diagnosis and Treatment. Iranian Journal of Blood and Cancer 2020; 12 (4) :111-120
URL:
http://ijbc.ir/article-1-1011-en.html
1- Department of Hematology, School of Paramedical, Shiraz University of Medical Sciences, Shiraz, Iran
2- Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran , tamaddon.g@gmail.com
Abstract: (3269 Views)
Thrombotic Thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathic disease, associated with thrombocytopenia and hemolytic anemia. It is caused by an enzymatic dysfunction responsible in cleavage of blood clotting factors. In this study we have tried to review the available approaches in diagnoses of the disease as well as treatment strategies. Based on the what the current review has provided, treatment policy depends on accurate diagnosis, it seems that developing a diagnostic and treatment guide for this disease is currently essential. Also, it’s necessary to study genetic types of TTP with more details because, hopefully, new techniques of gene therapy open a window to more stable treatments.
:
Review Article |
Subject:
Adults Hematology & Oncology Received: 2020/05/27 | Accepted: 2020/10/7 | Published: 2020/12/31